Use and effectiveness of pegfilgrastim prophylaxis in US clinical practice:a retrospective observational study

Use and effectiveness of pegfilgrastim prophylaxis in US clinical practice:a retrospective observational study

Abstract Background Febrile neutropenia (FN) is a serious complication of myelosuppressive chemotherapy. Clinical practice guidelines recommend routine prophylactic coverage with granulocyte colony-stimulating factor (G-CSF)—such as pegfilgrastim—for most patients receiving chemotherapy with an inte...

Full description

Bibliographic Details
Main Authors: Derek Weycker, Robin Doroff, Ahuva Hanau, Charles Bowers, Rajesh Belani, David Chandler, Alexander Lonshteyn, Mark Bensink, Gary H. Lyman
Format: Article
Language:English
Published: BMC 2019-08-01
Series:BMC Cancer
Subjects:
Febrile neutropenia
Pegfilgrastim
Neulasta
Granulocyte colony-stimulating factor
Online Access:http://link.springer.com/article/10.1186/s12885-019-6010-9

Internet

http://link.springer.com/article/10.1186/s12885-019-6010-9

Similar Items